New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
19:53 EDTTISI, IMS, CVR, VMI, BMYOn The Fly: After Hours Movers
HIGHER: IMS Health Holdings (IMS), up 5.13% after acquiring certain Cegedim businesses for $520M... Bristol-Myers Squibb (BMY), up 1.97% after a Phase 3 study of nivolumab was halted early due to superior data. LOWER: CVR Refining (CVR), down 4.05% after filing a secondary offering. DOWN AFTER EARNINGS: Team (TISI), down 7.27%... Valmont Industries (VMI), down 5.71% after lowering its FY14 EPS view.
News For IMS;BMY;CVR;TISI;VMI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
11:31 EDTBMYLion Biotechnologies TIL combo data an 'important' positive, says Piper Jaffray
After Lion Biotechnologies (LBIO) announced the report of positive results from a pilot trial of tumor infiltrating lymphocytes, or TIL, in combination with Bristol-Myers' (BMY) Yervoy in patients with metastatic melanoma, Piper Jaffray noted that the success rate for receiving TIL combo treatment was significantly higher than the prior result for TIL monontherapy. Piper said this fact highlights the combo approach may drive significantly broader application of TIL than it initially expected and the firm reiterated its Overweight rating and $21 price target on Lion shares.
March 26, 2015
07:30 EDTBMYDeutsche Bank to hold a conference
Pharma One-on-One Day is being held in Denver, Colorado on March 26.
March 24, 2015
08:02 EDTBMYBristol-Myers acquires exclusive license from Novo Nordisk for research program
Subscribe for More Information
March 20, 2015
07:55 EDTBMYAstraZeneca seen as potential target again if oncology drugs lag, Bloomberg says
Subscribe for More Information
March 19, 2015
10:02 EDTIMSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
March 18, 2015
16:25 EDTIMSIMS Health initiated with a Neutral at RW Baird
Target $28.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use